PESCIA, CARLO
PESCIA, CARLO
Universita' degli Studi di MILANO
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective
2024 C. Pescia, G. Lopez, D. Cattaneo, C. Bucelli, U. Gianelli, A. Iurlo
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer
2024 D. Massa, C. Vernieri, L. Nicolè, C. Criscitiello, F. Boissière-Michot, S. Guiu, A. Bobrie, G. Griguolo, F. Miglietta, A. Vingiani, R. Lobefaro, B. Taurelli Salimbeni, C. Pinato, F. Schiavi, S. Brich, C. Pescia, N. Fusco, G. Pruneri, M. Fassan, G. Curigliano, V. Guarneri, W. Jacot, M.V. Dieci
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
A Rare Case of Urinary Bladder Hamartoma Clinically Mimicking an Urothelial Carcinoma: A Case Report and Review of the Literature
2023 C. Pescia, G. Pini, G. Lopez, M. Malfatto, G. Brescia, S. Tabano, A. Del Gobbo
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
2023 G. Antonarelli, B. Taurelli Salimbeni, A. Marra, A. Esposito, M.A. Locatelli, D. Trapani, C. Pescia, N. Fusco, G. Curigliano, C. Criscitiello
TIGIT in Lung Cancer: Potential Theranostic Implications
2023 C. Pescia, G. Pini, E. Olmeda, S. Ferrero, G. Lopez
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
2023 A. Ranghiero, C. Frascarelli, G. Cursano, C. Pescia, M. Ivanova, D. Vacirca, A. Rappa, S.V. Taormina, M. Barberis, N. Fusco, E.G. Rocco, K. Venetis
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
Thymic Epithelial Tumors: An Evolving Field
2023 E. Kuhn, C. Pescia, P. Mendogni, M. Nosotti, S. Ferrero
Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour
2023 I.F. Aromolo, C. Pescia, D. Simeoli, S.A. Violetti, V. Ferla, F.G. Rossi, G.A. Croci
Granular cell tumor of the neurohypophysis presenting as a third ventricle mass
2023 G. Lopez, C. Pescia, C. Galli, M. Bramerio, A. Tosoni, M. Nebuloni, M. Ferrara, G. Bertani, L. Caschera, F.M. Triulzi, M. Locatelli, S. Tabano, G.A. Croci
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023 K. Venetis, F. Pepe, C. Pescia, G. Cursano, C. Criscitiello, C. Frascarelli, E. Mane, G. Russo, B. Taurelli Salimbeni, G. Troncone, E. Guerini Rocco, G. Curigliano, N. Fusco, U. Malapelle
Fibroblastic/cytokeratin-positive interstitial reticular cell tumor of the spleen with indolent behavior: a case report with review of the literature.
2022 C. Pescia, G. Lopez, U. Gianelli, G. Croci
Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes
2021 M. Lucioni, C. Pescia, A. Bonometti, S. Fraticelli, C. Moltrasio, A. Ramponi, R. Riboni, S. Roccio, G. Ferrario, L. Arcaini, G. Goteri, E. Berti, M. Paulli
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine
2021 C. Pescia, F. Boggio, G.A. Croci, R. Cassin, M. Barella, L. Pettine, G. Reda, E. Sabattini, C. Finelli, U. Gianelli